- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The natural history of progressive fibrosing interstitial lung diseases ; volume:20 ; number:1 ; day:14 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Respiratory research ; 20, Heft 1 (14.3.2019), 1-8, 12.2019
- Creator
-
Kolb, Martin
Vašáková, Martina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-1022-1
- URN
-
urn:nbn:de:101:1-2019040715244014351350
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kolb, Martin
- Vašáková, Martina
- SpringerLink (Online service)
Other Objects (12)
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial lung diseases in children
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases
Lung quantitative ultrasound to stage and monitor interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial lung diseases in children
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases
Lung quantitative ultrasound to stage and monitor interstitial lung diseases
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
Interstitial lung diseases in children
Serum biomarkers in interstitial lung diseases
Management of Fibrosing Interstitial Lung Diseases
Lung CCR6−CXCR3− type 2 helper T cells as an indicator of progressive fibrosing interstitial lung diseases
Interstitial lung diseases in the hospitalized patient
Surfactant gene polymorphisms and interstitial lung diseases
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
Diagnostic ability of multidisciplinary discussion in interstitial lung diseases and rare lung diseases